T1	HMM 341 363	safety and feasibility
T2	HMM 678 764	changes in infarct size and left ventricular ejection fraction 3 months after therapy.
T3	HMM 814 854	mean changes in infarct size at 3 months
T4	HMM 1004 1032	changes in ejection fraction
T5	HMM 1167 1184	ejection fraction
T6	HMM 1338 1348	stem cells
T7	HMM 1510 1525	number of cells
T8	HMM 1693 1747	myocardial infarct size and left ventricular function.
